Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 08:57:04 +0200Mon, 13 May 2024 10:20:00 +0200Human medicines European public assessment report (EPAR): Ryzodeg, insulin degludec,insulin aspart, Date of authorisation: 21/01/2013, Revision: 14, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ryzodegHuman medicines European public assessment report (EPAR): Ryzodeg, insulin degludec,insulin aspart, Date of authorisation: 21/01/2013, Revision: 14, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ryzodegMon, 13 May 2024 10:20:00 +0200Human medicineRyzodeg-H-C-2499-P46-0005 : EPAR - Assessment reporthttps://www.ema.europa.eu/system/files/documents/variation-report/wc500191604_en.pdfRyzodeg-H-C-2499-P46-0005 : EPAR - Assessment reporthttps://www.ema.europa.eu/system/files/documents/variation-report/wc500191604_en.pdfWed, 05 Aug 2015 02:00:00 +0200Human medicine